A Study to Evaluate the Safety, Tolerability, and Activity of KD025 in Subjects With Chronic Graft Versus Host Disease
Clinical trial NCT02841995 · COMPLETED
Trial details
- NCT number
- NCT02841995
- Sponsor
- Kadmon, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-15
- Primary completion
- 2022-05-12
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.